Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 8 January 2013
Vol. 6, Issue 257, p. ra3
[DOI: 10.1126/scisignal.2003197]


Editor's Summary

DUBbing Akt
Growth factors trigger the ubiquitination of the kinase Akt, which facilitates its activation. Yang et al. identified the tumor suppressor CYLD as a deubiquitinase (DUB) that inhibits Akt activity. CYLD associated with Akt under nutrient-deficient conditions and dissociated from Akt after growth factor stimulation. Compared to prostate cancer cells with CYLD, those that were deficient in CYLD showed increased glucose uptake and proliferation, processes that are enhanced by Akt activity, and developed into larger tumors when injected into mice. In individuals with primary prostate tumors, decreased abundance of CYLD correlated with increased activation of Akt. Thus, deubiquitination of Akt is required to reset its activity, and attenuation of Akt may contribute to the tumor-suppressive function of CYLD.

Citation: W.-L. Yang, G. Jin, C.-F. Li, Y. S. Jeong, A. Moten, D. Xu, Z. Feng, W. Chen, Z. Cai, B. Darnay, W. Gu, H.-K. Lin, Cycles of Ubiquitination and Deubiquitination Critically Regulate Growth Factor–Mediated Activation of Akt Signaling. Sci. Signal. 6, ra3 (2013).

Read the Full Text

Dynamic Ubiquitination of the Mitogen-activated Protein Kinase Kinase (MAPKK) Ste7 Determines Mitogen-activated Protein Kinase (MAPK) Specificity.
J. H. Hurst and H. G. Dohlman (2013)
J. Biol. Chem. 288, 18660-18671
   Abstract »    Full Text »    PDF »
The Akt DUBbed InAktive.
K. Lin (2013)
Science Signaling 6, pe1
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882